During the past decade, Instituto Oncologico Miraflores conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Oncologico Miraflores" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Oncologico Miraflores" are "Adult T-cell Leukemia-Lymphoma" (1 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Giant Cell Glioblastoma" (1 trials). Many other conditions were trialed in "Instituto Oncologico Miraflores" in a lesser frequency.

Most popular intervention types in "Instituto Oncologico Miraflores" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials), "Doxorubicin" (2 trials), "Paclitaxel" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Oncologico Miraflores" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Oncologico Miraflores". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Instituto Oncologico Miraflores, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Oncologico Miraflores, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".